Massive datasets containing the health records of millions of patients now underpin thousands of studies on drug safety, vaccines and treatment effectiveness.
Regulators are increasingly relying on them too.
Last December, then-FDA Commissioner Marty Makary announced plans to expand the agency’s use of “real-world evidence” in regulatory decisions.
“We’re …


